Epitope of cd66c specific to lung adenocarcinoma and antibody recognizing the same
AssigneeDinona Inc.
InventorsHyung-Geun SONG, Sang-Sun Yoon, Mi-Hyang Shin, Yu-Ri Moon
Life of this patent
Estimating the term…
Abstract
The present invention relates to epitope of CD66c specific to lung adenocarcinoma and antibody recognizing the same. The present invention relates to identifying epitope of CD66c specific to lung adenocarcinoma, antibody recognizing the same, cell lines producing the same and the applications in diagnosis, prevention and treatment of lung adenocarcinoma by using the same. The above CD66c epitope is specific to lung adenocarcinoma cells, and therefore the antibody or its fragment recognizing the epitope can be used in compositions to diagnose, treat and prevent lung adenocarcinoma cells.
Claims13
An isolated polypeptide comprising an epitope of CD66c (Cluster of Differentiation 66c) represented by amino acid sequence of SEQ ID:
- 7.
Dependencies are inferred from the claim text.